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ABSTRACT
In the past years, extracellular vesicles (EVs) have become an important field of research since EVs
have been found to play a central role in biological processes. In pathogens, EVs are involved in
several events during the host–pathogen interaction, including invasion, immunomodulation,
and pathology as well as parasite–parasite communication. In this report, we summarised the role
of EVs in infections caused by viruses, bacteria, fungi, protozoa, and helminths based on the talks
and discussions carried out during the International Society for Extracellular Vesicles (ISEV)
workshop held in São Paulo (November, 2016), Brazil, entitled Cross-organism Communication
by Extracellular Vesicles: Hosts, Microbes and Parasites.
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The ISEV satellite meeting
Extracellular vesicles (EVs) are prokaryotic and eukar-
yotic cellular components involved in communication
and in several processes ranging from infectious to
inflammatory diseases [1,2]. The structural and func-
tional characterisation of EVs has been focused on
vesicles isolated from the extracellular milieu of cul-
tured cells in normal or pathological conditions and
from microorganisms. The general term extracellular
vesicle has currently been proposed to include exo-
somes, microvesicles, and apoptotic bodies, which
vary in size, number, and biogenesis [3].
Following a growing interest in the EV field for
10 years, a group of scientists created the
International Society for Extracellular Vesicles (ISEV),
following the International Workshop on Exosomes
organised in Paris in January 2011. ISEV is a global
society, whose mission relies on spreading education,
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communication, and science among the different levels
of academia. Since then, six annual meetings promoted
by the Society were held in different cities including
Göteborg (2012), Boston (2013), Rotterdam (2014,
2016), Washington D.C. (2015), and Toronto (2017).
ISEV has also promoted satellite workshops that con-
gregated 40–60 participants and have so far occurred in
New York (2012), Melbourne (2014), Budapest (2013),
and Singapore (2015), among others. Considering that
infectious diseases are a major health problem in Brazil
and other tropical countries, an ISEV workshop
focused on EVs from pathogens was held in São
Paulo, Brazil, in 2016. This meeting was organised by
local groups working in infectious disease-related EVs
and ISEV Board and had the participation of scientists
and students coming from many Brazilian cities as well
as other countries. The main topics included: EVs iso-
lation and characterisation; EVs in viruses, bacteria,
fungi, protozoa and helminths; the role of EVs in
pathogen–host interactions. Before the meeting, an
Education Day including introductory talks to graduate
students and postdocs was organised. Below we sum-
marised the highlights of the event with a brief back-
ground on the EVs role in host–pathogen interactions.
The role of pathogen EVs in the interaction
with the host
During evolution, human pathogens have evolved
complex life cycles that often involve different hosts
at intracellular or extracellular residencies, and that
evoked a wide range of clinical outcomes from asymp-
tomatic infections to severe disease, including death
[4]. Host–pathogen interactions thus require fine-
tuning intercellular communication adapted to the par-
ticularities of each microorganism for which EVs seem
to play a key role [1,5]. In fact, since the molecular
composition of EVs seems to comprise both random
and selected cargo [6], EVs are able to transfer func-
tional information to recipient cells that signal normal
and pathophysiological processes. Moreover, as such
selected cargo contains pathogen-derived molecules,
EVs also represent novel approaches for identifying
novel biomarkers of disease, and for discovering anti-
gens for vaccination [7].
Several independent observations have demon-
strated that pathogen-derived EV cargos seem to be
highly secreted in small EVs coming from virus
infected cells [7]. Yet, we are far from understanding
the mechanism(s) involved in this selective sorting. On
the other hand, this is not so obvious for pathogen EVs
in infections caused by bacteria, fungi or parasites. In
Mycobacterium tuberculosis, the machinery for
ubiquitination was implicated in incorporation of bac-
terial proteins into exosomes [8], although it is
unknown whether this mechanism is also used by
other bacteria or microorganisms. Clearly, studies on
the mechanisms for sorting selective pathogen-derived
cargo into EVs might pave the way for discovering
inhibitors of such mechanisms.
Another major topic in host–pathogen interaction is
functional studies on the effect of transferring informa-
tion to recipient cells. Several examples currently sup-
port that this transfer might facilitate the colonisation
of niches for pathogen invasion, exacerbate clinical
symptoms, and trigger immune responses, among
other effects [9,10]. A recent report on
Paracoccidioides brasiliensis, which causes major fungal
lung complications, shows the importance of EVs in
the intercellular communication with the host cells
[11]: there was a dose-dependent effect on the produc-
tion of murine macrophage pro-inflammatory media-
tors upon incubation with fungal EVs, which induced a
potent and specific M1 polarisation. Moreover, EVs
stimulated conversion of non-protective M2-
macrophages to protective M1-polarised cells with
higher fungicidal activity. Several other studies show
the pathogen EV elicitation of immune responses in
human parasitism that directly affect the outcome of
infection [12]. Unveiling mechanistic insights of such
outcomes will provide the basis for developing alter-
native control strategies.
A great deal of research on pathogen EVs is directed to
their use as novel therapeutic agents [13]. Indeed, since
the original work on the demonstration that dendritic
cell-derived exosomes primed with Mycobacterium anti-
gens were able to confer protection, there are growing
examples of the EV use as vaccines in other bacterial,
fungal, and parasitic infections [12]. The major challenge
ahead, however, is to understand the mode-of-action of
EV-based vaccines. A significant advance on this relevant
topic has recently been published using a mouse malaria
model [14], where immunisation with exosomes obtained
from infected reticulocytes evoked long-lasting protection
from a lethal challenge with Plasmodium falciparum. In
that model, splenectomy before immunisation abolished
the protective effect of vaccination, but immunisation
elicited effector memory T-cells that, unlike effector
memory T-cells from experimental infection, were not
exhausted. Further understanding of the mechanism of
action of EV-based vaccines will guide more rational
efforts in developing cell-free vaccines against pathogens,
and will speed-up regulatory issues for their use in
human clinical trials.
In terms of diagnostics, even though the EV mole-
cular cargos of different pathogens are well known [1],
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there are few examples of their use as infection bio-
markers. Yet, a recent report on the characterisation of
miRNAs from Schistosoma mansoni EVs in human
samples demonstrated their potential in this growing
research area [15]. In summary, research on the bio-
genesis, molecular composition, and function of EVs in
host-pathogen interactions is a growing field with clear
translational implications for eradicating infectious dis-
eases that affect the human kind.
Protocols for pathogens EV purification and
characterisation
Working with pathogen EVs can be very challenging
since each microorganism has peculiarities that are
inherent to its biology. Pathogenic microorganisms
may develop inside host cells, in the extracellular matrix,
circulate in the body fluids, depending on the species,
developmental stage, and mode of transmission. Some
pathogens are transmitted by arthropod vectors such as
protozoan parasites, and vary according to the host
environment, or culture conditions. Common changes
are alterations in the composition and cell walls and the
type of secreted materials. All of these will affect EV
release. Moreover, the release of EVs can be affected by
multiple host factors, as is the case of helminths. In this
context, the protocols for EVs isolation from pathogens
should be standardised according to the cell model and
to the peculiarities of the organism. Another major
concern is that each organism releases different types
of vesicles with unique characteristics including size
profile. Therefore, how to separate and characterise
EVs and define “gold standards” from pathogens is a
major challenge.
Over the past years a range of methods to separate and
probe EVs have been assessed, making EV preparations
available in increasing amounts. Paolo Bergese (Universitá
degli Studi di Brescia, Italy) showed a COlloidal
NANoplasmonic (CONAN) assay for purity assessment
and titration of EVs [16], which used in combination with
atomic force microscopy (AFM) and helium ion micro-
scopy (HIM) allowed to assess the impact of the purity of
EV preparations on their biological activity [16]. Bergese
also points out that colloidal properties of EVs (such as
size, stiffness, surface charge, interfacial energy, hydrody-
namic behaviour, adhesion, spreading) might play a major
role in the case of communication networks belonging
themselves to the biocolloidal domain, such as microbiota
populations Joel Rozowsky (Yale University, USA) showed
the exceRpt pipeline (github.gersteinlab.org/exceRpt) of
the Extracellular RNA Communication Consortium
(ERCC) has for several years allowed users to analyse
small-RNA-seq data from extracellular preparations. A
major feature of the pipeline is a comprehensive series of
quality filters. Lorena Martin-Jaular (Institute Curie,
France) spoke on the “diversity of vesicles and rigor in
isolation.” Beginning with the Théry laboratory’s discov-
eries on the protein components of EVs with different sizes
and densities [17], Lorena Martin-Jaular then shared her
experience with purification of EVs from HIV-1 infected
Jurkat T-cells using Iodixanol velocity gradients. EVs are
present in the lighter fractions, while HIV virions predo-
minant in the heavier fractions. She observed slightly less
syntenin, possibly also CD9, in virus fractions.
Acetylcholinesterase, often used as a surrogate marker of
EVs, was found not to be a reliable marker: it was present
only in the lightest fractions and had only minimal overlap
with EVs.
Laura de la Canal (University of Mar del Plata) gave
a second overview talk, “Lessons from plants and fungi.”
De la Canal related her experience with the challenges of
investigating EVs in organisms in which EVs have not
yet been well studied [18,19]. Investigators in uncharted
waters can expect resistance and only slow recognition
of new findings. Vilma Regina Martins (A.C.Camargo
Cancer Center, Brazil) discussed regulation of exosome
secretion. André Vettore (UNIFESP, Brazil) used a
Cholera Toxin B and Annexin V to affinity purifies
EVs from cancer patient samples, finding various mar-
kers for cisplatin resistance. Next presentation, Joel
Rozowsky (Yale University, USA) introduced the audi-
ence to the US NIH Extracellular RNA Communication
Consortium’s exceRpt pipeline for exogenous exRNA
analysis. Allan Stensballe (Aalborg University,
Denmark) shared his experience with proteome analysis
of non-eukaryotic EVs.
Virus
Viruses are small infectious particles that require a host
cell to survive and multiply. A distinguished feature of
viruses is that these agents directly affect many intra-
cellular pathways of their host cells. It is now clear that
the mechanisms involved in EV biogenesis described
for mammalian cells share many similarities with that
of assembly and budding of many enveloped viruses
[6,20]. In addition, several types of non-enveloped
viruses have been shown to exit intact cells via enclo-
sure in EVs, which allows hiding from the immune
system [21]. Virus infection can influence the EV
population released from infected cells by manipulating
EV production with the incorporation of proteins and
nucleic acids from both host and viral origin into those
EVs. Therefore, enclosure of virions and viral compo-
nents in EVs can impact host-virus interactions and
antiviral immunity. EVs from virally infected cells may
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also help to enhance viral propagation both via recep-
tor-dependent and receptor-independent mechanisms
and promote the possibility of genetic exchange
between the viral species, which will enhance the fit-
ness of the overall population.
Despite the progress in the field, the mechanisms by
which viruses affect the molecular composition and
release of EVs still need to be clarified, and the knowl-
edge obtained can help the development of better anti-
viral therapies and vaccines. Several studies were
presented in the ISEV workshop focusing on the bio-
genesis, release and purification of EVs in the context
of infection by different viruses, such as HIV, Dengue,
HTLV-1, and EMCV. In most studies, differential cen-
trifugation of culture supernatant is applied, followed
by further purification on iodixanol density or velocity
gradients and probing with specific antibodies against
virus molecules and EV markers. The presented data
indicated that it is particularly difficult to discriminate
enveloped viruses from EV due to the lack of discrimi-
nating protein markers and overlap in their buoyant
density. Most likely, the population of membrane-
enclosed particles released by the infected cells is highly
heterogenous, containing EV with graded levels of host
and viral factors and replication-capable viruses.
Naked viruses, on the contrary, can be separated
from EV and EV-enclosed viruses based on buoyant
density. However, more advanced methods will need to
be developed to be able to analyze the heterogenous
mix EV released by infected cells, which may consist of
constitutively released EV, EV that contain infectious
virus, and infection-induced EV that do not contain
virus. Being able to purify these different EV types
based on discriminatory markers will help to assess
the contribution of each of these EV types to virus
progression or antiviral immunity.
Kenneth Witwer (Johns Hopkins University, USA)
began the session with an overview of virus and EV
diversity and how many of the challenges faced in the
virology field also apply to EV studies. EVs and envel-
oped viruses like HIV share biogenesis pathways [22,23]
and are difficult to separate [24,25], similar to the case
for EVs and lipoproteins [26]. Findings on virus entry
into cells may provide clues as to how EVs deposit cargo
into cells [27]. A cautionary note was sounded for
combined studies of EVs and viruses, as EV-depleted
culture conditions were found to influence production
of retroviruses, as well [28]. Other presentations in this
session included the work of Sharon Martins
(FIOCRUZ, Brazil), on dendritic cells (DCs) and dengue
virus. In dengue, an initial infection can be followed by
re-infection by different serotypes, eliciting a cytokine
storm and antibody-dependent virus replication. In her
studies, Martins examined two dengue strains with dif-
ferent outcomes: 290 and 5532 (DENV3). These result
in fever without complication and fatal bleeding, respec-
tively. Martins reported that DC EVs may protect a
subpopulation of viruses by engulfing or aggregating
them. Furthermore, miRNAs associated with immune
evasion were differentially expressed during exposure to
the different viruses.
Bacteria
EVs from Gram-negative bacteria are known as outer-
membrane vesicles (OMVs) but this denomination is
not commonly applied to Gram-positive bacteria or
Mycobacteria [29]. OMVs are crucial for intercellular,
interspecies, and interkingdom communication; how-
ever, their biogenesis is not completely understood.
OMV contents and surface components are highly
variable, often involved in virulence and may include
proteins, phospholipids such as lipopolysaccharide
(LPS), peptidoglycan, and nucleic acids depending on
the species/strains [30]. The LPS is a strong TLR4
agonist with importance in the pro-inflammatory
events following bacterial infection [31–34]. OMV
DNA contents activate TLR9 that also trigger inflam-
matory responses [2,35].
Joëlle Fritz (University of Luxembourg, Luxembourg)
presented results showing that OMVs released from
Salmonella enterica, contains small RNA that may be
able to modulate the human immune system. Tonya
Duarte (IFBA, Brazil) characterised morphologically EVs
released from macrophages infected with M. tuberculosis
and showed that these EVs also modulate host immune
response. Reiudun Øvstebøo (Oslo University Hospital,
Norway) showed that microparticle-associated tissue fac-
tor activity correlates with plasma levels of bacterial lipo-
polysaccharides in patients with meningococcal septic
shocks of meningococcal meningitis present in the
plasma of patients contributed to the disseminated vas-
cular pathogenesis. Kristian Riesbeck (Lund University,
Sweden) presented results indicating that OMVs from
Moraxella catarrhalis and Haemophilus influenzae
affected the immune system and can carry β-lactamases
that induce increased survival of other bacteria. Infection
of salmons was also correlated in the work of Hanne C.
Winther-Larsen (University of Oslo, Norway) with the
type and the capacity of OMVs released by Piscirickettsia
salmonis to upregulate several proinflammatory genes.
The protocols developed to isolate bacterial EVs
usually involve differential centrifugation, filtration, and
ultracentrifugation [35,36]. A summary of the multiple
roles, isolation, characterisation and use of pathogenic
bacteria was illustrated by Yong Song Gho (POSTECH,
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Republic of Korea) available in a web portal (http://stu
dent4.postech.ac.kr/bevpedia/xe/xe/.) However, proteo-
mic studies revealed that ultracentrifugation does not
completely remove bacterial contaminant, such as protein
aggregates or membrane debris, and some authors have
proposed to use density gradient ultracentrifugation to
obtain cleaner EV preparations [37]. Transmission elec-
tron microscopy (TEM) is generally used to confirm EV
purification since there are no specific antibodies or
probes for labelling bacterial EVs. This and other aspects
concerning the study of bacterial OMVs/EVs have been
highly covered in the meeting because they need to be
overcome to ensure reliability of the results. For example,
Michael W. Pfaffl (Technical University of Munich,
Germany) discussed multiple isolation and characterisa-
tion methods from different bacterial and food sources in
farm animals. The research aims to get more insights in
the communication via OMVs/EVs of a healthy and
diseased microbiome in food-producing animals. Goal is
to increase animal health and welfare and to reduce
medication, in particular antibiotic, in animal husbandry.
A vital communication between kingdoms in the mam-
malian gastro intestinal tract (GIT) is supposed by an
exchange of OMVs/EVs that may interact in a triangular
way between microbiome and host, majorly triggered by
nutrition or medication. Hence the GIT transfer of spe-
cies-specific small-RNAs via OMVs/EVs was investigated
by a robust bioinformatical analysis on the containing
small-RNAs. The spike in of non-OMV/EV controls to
monitor the vesicular extraction and purification proce-
dures and efficiency might be useful in functional studies.
Nevertheless, those controls are novel, not well estab-
lished and they will certainly vary depending on the
spike-in model organism. Allan Stensballe (Aalborg
University, Denmark) presented current challenges and
pit-falls in proteogenomics and proteomic identification
and characterisation of bacterial proteins from non-
genome-sequenced bacteria.
A robust bioinformatic analysis was considered essen-
tial for this task. The addition of non-EV controls to
monitor the EV extraction and purification procedures
might be useful in functional studies. Nevertheless, those
controls are still not well established and they will cer-
tainly vary depending on the bacterial model. Another
important discussed issue to ensure reproducibility and
result comparisons is the bacterial culture conditions that
should be standardised, or at least clearly detailed in the
reports. These conditions regard medium type (defined
or complex), growth phase, cell viability, and others that
might change EV production and features. Bacterial
OMVs/EVs have already been tested as vaccines in
numerous works, and therefore the purity and
reproducibility of the material must be guaranteed for
use in different biotechnology processes.
The OMVs are currently investigated as both vaccine
adjuvants and therapeutics delivery vehicles. Whereas
most published studies on EVs have focused on mam-
malian systems, the bacterial world could also have
much to contribute to basic science and clinical appli-
cations. The Culture media used in most bacterial stu-
dies are so-called “rich” media, with complex
components derived from biological sources such as
yeast extract or meat extracts. A participant correctly
noted that many bacterial strains could currently be
grown in only one established culture medium. Since
EVs or EV-like particles can be plentiful in rich media,
defined “minimal” media culture conditions should be
established unless (1) there is a reliable means to dis-
tinguish media EVs from those produced by the organ-
ism of interest or (2) the cultures produce so many EVs
that culture media contaminants are only a small per-
centage of total EVs. However, for rich and minimal
media alike, one must remember to assess the simila-
rities and differences of the growth conditions with
what the organism might encounter in its native envir-
onment. For the most widely used separation method,
ultracentrifugation, participants noted that differences
between a 100,000 xg ultracentrifuge pellet and other
fractions have not been established for EVs from some
organisms. Additional comparative studies of UC and
other methods would be useful. For gradient ultracen-
trifugation, some preferred sucrose or iodixanol, and
there was a difference of opinion about whether EVs
could be stored in these gradient materials and how.
One group stored iodixanol fractions at 4°C, while
another froze them at −80°C. There is clearly room
for methodology comparisons. Collection timing:
phase, concentration, and cell death. While more EVs
(per bacterium) might be present in stationary phase,
the molecular profiles of vesicles released during differ-
ent growth phases may be different (along with those of
the releasing cells). This is consistent with the role of
EVs in quorum sensing, as populations avoid over-
growth that may be harmful to themselves or a host
organism. Therefore, the timing of harvest and popula-
tion density (e.g. optical density) should be monitored,
specified, and standardised for within- and between-
study comparisons. Likewise, the ratio of dead and live
cells should be reported, and populations with death
over a pre-specified threshold (usually 5% or below)
should not be used for EV separation.
The Participants identified an important question to
solve: how to measure and report purity of EVs? An ideal
purity measurement might include an EV-specific marker
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or markers and a measure of total material or contam-
inating materials. In the mammalian EV literature, several
metrics have been proposed. For example, protein con-
centration as a function of particle count [38] or EV
protein marker(s) versus total protein [39]. Molecular
“fingerprinting” assays are also in use [39]. For bacterial
studies, generating a pan-bacterial EV antibody may very
well be out of reach. However, existing anti-bacterial
antibodies can be tested, and a Workshop participant
reminded the group that generating a new antibody is a
relatively simple process. If the perfect antibody to a
single protein or strain cannot easily be identified, more
general assays may also be helpful. LPS assays (gram-
negative) and LTA assays (gram-positive) might identify
properly separated EVs. Lipid/sterol measurements
should be considered. Functional readouts. Whereas
large quantities of material are often needed for omics
profiling, minute amounts of EVs may elicit responses in
functional assays. One proposal was to use macrophage
responses to gauge bacterial EV potency. Care must of
course be taken to ensure that signals are elicited by EVs
and not by contaminating soluble factors. Contamination
versus co-action, the issue of contamination was also
found to be interesting from a conceptual perspective.
Possibly, EVs do not act alone, but in concert with
materials we might identify as contaminants. Is a surface-
associated (but not integral) protein a contaminant? Must
RNAs be located in the EV lumen to be EV RNAs? Is it
possible to purify a population of EVs away from con-
taminants to the point that potency is lost? In that case,
an EV prep might become “too pure”?
Fungi
EVs isolated from the culture supernatant have been
characterised in human pathogenic species like
Cryptococcus neoformans, Paracoccidioides brasiliensis,
Candida albicans, Malassezia sympodialis and others,
in addition to Saccharomyces cerevisiae. The heteroge-
neity in the population sizes and electron density sug-
gests that different routes are involved in fungal EV
biogenesis.
Before reaching the extracellular space, fungal EVs
must traverse a thick cell wall that is mainly consti-
tuted of structural polysaccharides (glucans, chitin,
and mannoproteins). Cryptococcus spp. also has a
more external large capsule composed mainly of glu-
curoxylomannan (GXM) of high molecular mass and
EVs not only traverse the capsule, but also contribute
to its formation. Fungal EVs carry virulence factors
within their cargo, which is constituted of a large
variety of proteins, carbohydrate (glycogen, glucan,
mannose oligosaccharides, α-galactosyl epitopes),
small and messenger RNA, lipids, and melanin
[35,40,41]. Virulence factors carried in fungal EVs
include GXM, heat-shock proteins, superoxide dismu-
tase, catalases, proteases, laccase, and urease [42,43].
At least 60% of the proteins seen in fungal EVs have
also been described in the fungal cell wall, suggesting
that they are due to the release of EV contents or to the
transient presence of the vesicles in this compartment.
Fungal EV biogenesis seems to involve the formation
of ectosome, exosomes, and inverted macropinocytosis,
as observed in electron microscopy images of wild type
and mutant fungal cells. On the other hand, among the
mechanisms proposed to explain how EVs cross the
fungal cell wall, the most plausible envisions the for-
mation of cell wall pores by the enzymatic action of
cell-wall modifying enzymes contained in EVs
[42,44,45]. The finding of cell wall remodelling and
other active enzymes, like proteases, in fungal EVs
corroborates this hypothesis.
In the ISEV meeting we had the chance to hear from
Juliana Aparecida Rizzo Balancin (UFRJ, Brazil) about
the characterisation of EVs in Aspergillus fumigatus,
which is an opportunistic pathogen that lives in the
mycelial form. EVs have been isolated from protoplasts
and carried cytokine-inducing molecules, besides
enzymes and glycans potentially involved in cell wall
formation. We also had a talk from Karen Spadari
Ferreira (UNIFESP, Brazil) on the participation of
Sporothrix brasiliensis EVs in the murine innate response
through the in vitro interaction with macrophages and
dendritic cells and about the characterisation of the over-
all EV RNA content in various fungal species using
RNA-seq. Rosana Puccia (UNIFESP, Brazil) showed the
lipid and glycan composition and the presence of sRNA
(small nucleolar RNA, transfer RNA and microRNA) in
vesicles released by P. brasiliensis and Paracoccidioides
lutzii. Allan Stensballe (Denmark) presented the isolation
and characterisation of beer-derived EVs OMVs.
The discussions on issues related to fungal EV iso-
lation and characterisation revealed that the fungal as
the bacterial systems deserve attention on the standar-
disation of growth conditions, including culture media
and growth phase choice to make the results compar-
able and trustable. Defined medium should be pre-
ferred over complex media and protein aggregates
should be avoided. Current fungal EV isolation proto-
cols are based on serial centrifugation and filtration,
while density gradient ultracentrifugation and gel fil-
tration have been proposed to be used routinely after
that. The lack of general biomarkers has hampered the
development of affinity-chromatography protocols and
so the community should pay more attention to find
markers for fungal EVs [11,40,42–44].
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Protozoa
Parasites are known to shed and release EVs that
function as cell-to-cell effectors in host–parasite inter-
action including regulation of the host immune system
as well as in parasite–parasite communication. These
observations have been corroborated for different
Kinetoplastidae protozoan such as Trypanosoma
cruzi, Trypanosoma brucei and Leishmania spp),
Apicomplexa (Toxoplasma gondii, Plasmodium falci-
parum), Amoebae, Giardia and Trichomonas vaginalis.
These parasite EVs contain a wide variety of molecules,
including proteins, lipids, and RNAs (non-transcribed
RNAs and microRNAs). They have been explored as
biomarkers for diagnosis and disease monitoring, and
as immune modulators to suppress or stimulate the
immune system, vectors for drug delivery, vaccination,
and therapeutic agents [1,46–54].
The talk of Adriana Oliveira Costa (UFMG, Brazil)
highlighted the morphological characterisation and pro-
tein composition of EVs obtained by the first time from
four different strains of Acanthamoeba ssp. The release of
EVs of Giardia intestinalis was characterised by proteomic
analysis by Ingrid Evans-Ossens (Instituto de Pesquisa
Pelle Pequeno Príncipe, Brazil). Armando De Menezes-
Neto (FIOCRUZ, Brazil) demonstrated EV enrichment
from Leishmania infantum and L. braziliensis and the
presence of major surface glycoconjugates such as GP63,
a virulence factor of several Leishmania species [54].
Seminal findings reported by Olivier’s group showed that
L. major and L. infantum promastigotes release EVs in vivo
in the midgut of the sand fly vectors and to play an
important role in the transmission and propagation within
the host [55]. Co-inoculation of Leishmania EVs and pro-
mastigotes was found to favour a Th17-dependent hyper-
inflammation paralleled with an exacerbated infection.
The compositional variability and the role of different
T. cruzi isolates was illustrated by the groups of Ana
Claudia Torrecilhas (UNIFESP, Brazil) and Rodrigo
Pedro Soares (FIOCRUZ, Brazil), indicating a possible
correlation with the different Chagas’ disease profiles.
For Apicomplexa parasites, Vera Pereira-Chioccola
(Adolfo Lutz Institute, Brazil) highlighted the presence
of small RNA and microRNA in T. gondii tachyzoite
EVs, which could modulate the host immune response.
Portillo brought to light new data demonstrating that
reticulocyte-derived EVs from natural malarial infec-
tion can signal mechanisms between the bone marrow
and the spleen, thus revealing molecular mechanisms
related to the clinical syndromes. In line with this,
Patrícia Xander (UNIFESP, Brazil) showed that B-1
cells infected with L. amazonensis release vesicles that
modulate macrophage functions.
The most discussed topic was regarding the different
methodologies used to obtain and characterise EVs
released from cultured parasites and from infected
cells. This was particularly relevant since most EVs
contained cell surface components and it was ques-
tioned which mechanisms are involved in EV release.
It was proposed that identification of specific EV mar-
kers is still necessary in this field.
Helminths
Parasitic worms (helminths) are a constraint in livestock
production and have major impact on the health of the
one billion people infected. Infections are associated
with profound suppression of host inflammatory
responses and directing the immune responses towards
regulation favouring parasite survival and chronic infec-
tions. Due to the complex nature of helminths and the
multiple way they interact with the host immune system
development of effective vaccines have failed to a large
extend so far. As EVs released from helminths may
provide fundamental new insight into the immunomo-
dulatory properties of these worms and provide a novel
entry point for vaccine development research groups
have characterised EVs released from these organisms
and started to explore their functions in host-parasite
interactions. These studies have high level of complexity
due to the presence of several compartments and the
difficulty in differentiating between EVs from the para-
site and the host [1,56,57]. To visualise the EV uptake by
host cells Antonio Marcilla (Universitat de Valencia,
Spain) stain the EVs and their uptake in intestinal
IEC-18 cells can then be followed using confocal micro-
scopy. Studies were presented on the characterisation of
EVs released by adults of different trematode species,
where several worm specific proteins as well as nucleic
acids have been identified. Current data on EV compo-
sition, as well as preliminary data on their use in con-
trolling the disease (i.e. in diagnosis, vaccination, and
treatment) were shown, as well as preliminary studies on
their possible therapeutic use in a murine model of
ulcerative colitis.
Peter Nejsum (now at Aarhus University, Denmark)
focused on EVs of nematodes of veterinary importance,
the whipworm Trichuris suis, the giant round worm,
Ascaris suum, and the nodular worm, Oesophagostomum
dentatum. Due to related host physiology and closely
related parasites species in humans, the pig-parasite
model also serves as a good model for similar worm infec-
tion in humans. Eline Palm Hansen (Nejsum’s group)
presented evidence that EVs released from these species,
contained miRNAs and were taken up by cells in culture.
JOURNAL OF EXTRACELLULAR VESICLES 7
In addition, to explore the ability of EVs to suppress
proinflamatory responses in dendritic cells in vitro studies
have been conducted.
Maria Eugenia Ancarola (University of Buenos
Aires, Argentina) presented results on cestodes EVs,
focusing on the characterisation of the vesicles pro-
duced by larval stages of Taenia crassiceps and
Mesocestoides corti. The presence of particular
miRNAs as well as specific proteins was presented,
representing putative new targets for non-invasive
diagnosis.
Concluding remarks: EVs in diagnostic, adjuvants,
vaccine and biotechnological applications
During the presentations and discussions the workshop
provided new perspectives on the role of EVs in host–
pathogens interactions. This may pave the way for the
development of new diagnostic tools, preventive stra-
tegies and to design new therapeutic approaches. A
major outcome was the necessity to establish robust
protocols for the isolation and characterisation of EVs
from the very diverse group of pathogens, and impor-
tantly, the identification of specific EV markers for
each species. Finally, the workshop created an environ-
ment for future collaborative studies between scientists
working with different pathogens.
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